Recent Articles

July 30, 2015 3:15 pm
Gianfranco Zeppetelli, Deals Analyst, GlobalData
Teva's bid for Allergan’s generics business illustrates that it has given up on its pursuit of rival Mylan NV. Read more...
July 29, 2015 9:39 am
Lindsay Hock, Editor
Now, (July/August) is the time frame when flu vaccines start to be delivered to protect the public for next year. Yet, the road to an efficient vaccine is a difficult one. Just as with any virus, influenza mutates in its genetic material, potentially causing changes in the strains present each year. Read more...
July 29, 2015 10:13 am
Cynthia Fox, Science Editor
Gene therapy restored vision to blind patients by strengthening visual pathways from the retina, through the brain’s white matter, into the brain’s visual cortex, says a report in Science Translational Medicine. Read more...
July 29, 2015 10:15 am
Nurry Hong, Managing Director; Sue St. Sure, Managing Director; and Max Cambras, Life Sciences Expert, Manager, of L.E.K. Consulting
With the rise of biologics, drug delivery presents new challenges as many companies are still taking a fragmented approach, resulting in delayed (or suboptimal) product launches and life cycle management. The problem is that it’s extremely difficult, if not impossible, to fix drug delivery challenges after the fact, so companies need a clear strategy in advance. Read more...
July 28, 2015 3:26 pm
Lindsay Hock, Editor
 Little do we think of the testing behind the medications prescribed to us that improve the quality of our lives. Yet, stringent testing is needed for any pharmaceutical or health care product to hit the shelves of your local convenience store. Read more...
July 28, 2015 3:55 pm
Cai Xuan, Ph.D., Oncology and Hematology, GlobalData
This observation opens up a market for companion biomarker tests that can be used to identify patients who would likely benefit from PD-1/PD-L1-targeted therapies. Read more...
July 27, 2015 10:40 am
Ryan Bushey, Associate Editor
The test is able to diagnose the virus in 15 minutes. Read more...
July 21, 2015 3:55 pm
Andrew S. Thompson, Ph.D., Senior In Vitro Diagnostics Analyst, GlobalData
Other significant drivers of cancer companion diagnostics market growth include increasing disease incidence, accelerating demand for targeted therapies and economic pressures to develop maximally efficient treatments. Read more...
July 21, 2015 9:24 am
Cynthia Fox, Science Editor
A July Laboratory Investigation report found aspirin may render the environment of cancer stem cells, which can linger post-chemo, hostile to replication. Aspirin may also ward off breast cancer prophylactically, according to the study led by Sushanta Banerjee, Ph.D., research director of the Cancer Research Unit at the Kansas City (Mo.) Veterans Affairs Medical Center. Read more...
July 21, 2015 8:32 am
Daian Cheng, Ph.D., Infectious Disease Analyst, GlobalData
The low price of generic drugs not only will limit the sales of existing treatment, it also poses an entry barrier for new therapies. Read more...
Subscribe to Drug Discovery & Development